Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.002
Sell
RSI(14)
51.926
Neutral
STOCH(KDJ)(9,3,3)
65.883
Buy
ATR(14)
0.022
High Vlolatility
CCI(14)
47.745
Neutral
Williams %R
20.345
Buy
TRIX(12,20)
-1.043
Sell
StochRSI(14)
100.000
Buy
View Detailed Chart
0.000
Close （ET）Quotes delayed by 15 min
--Market Cap
--P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+29.41%
5 Days
+12.41%
1 Month
-31.56%
6 Months
-18.80%
Year to Date
-41.81%
1 Year
-42.25%
View Detailed Chart
Agency Rating
No Data
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Sell
Moving Average
Indicators
Value
Direction
MA5
0.032
Sell
MA10
0.031
Sell
MA20
0.039
Sell
MA50
0.035
Sell
MA100
0.042
Sell
MA200
0.041
Sell
News
More news coming soon, stay tuned...
Company
LakeShore Biopharma Co Ltd, formerly YS Biopharma Co Ltd, is a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer. The Company's vaccine product YSJATM rabies vaccine has been commercialized. The Company also has four product candidates under various clinical development stages, including PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, PIKA YS-ON-001 and PIKA YS-HBV-001, and four preclinical stage product candidates, targeting HBV, influenza and cancer with enormous medical demand. In addition, the Company is working on a series of therapeutic targets, rabies and products at the discovery stage.
Company codeLSBPW
CompanyLakeShore Biopharma Co Ltd
CEOMr. Dave Chenn
Website
